GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » Cash Conversion Cycle

CCLD (CareCloud) Cash Conversion Cycle : 12.51 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is CareCloud Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

CareCloud's Days Sales Outstanding for the three months ended in Dec. 2024 was 40.01.
CareCloud's Days Inventory for the three months ended in Dec. 2024 was 3.31.
CareCloud's Days Payable for the three months ended in Dec. 2024 was 30.81.
Therefore, CareCloud's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2024 was 12.51.


CareCloud Cash Conversion Cycle Historical Data

The historical data trend for CareCloud's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareCloud Cash Conversion Cycle Chart

CareCloud Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.62 13.88 18.55 14.17 12.65

CareCloud Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.01 9.52 9.56 10.47 12.51

Competitive Comparison of CareCloud's Cash Conversion Cycle

For the Health Information Services subindustry, CareCloud's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareCloud's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareCloud's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where CareCloud's Cash Conversion Cycle falls into.


;
;

CareCloud Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

CareCloud's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=40.61+3.12-31.08
=12.65

CareCloud's Cash Conversion Cycle for the quarter that ended in Dec. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=40.01+3.31-30.81
=12.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareCloud  (NAS:CCLD) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


CareCloud Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of CareCloud's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


CareCloud Business Description

Traded in Other Exchanges
Address
7 Clyde Road, Somerset, NJ, USA, 08873
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Executives
John N Daly director 390 STANWICH ROAD, GREENWICH CT 06830
Cameron Munter director 295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Mahmud Ul Haq director, 10 percent owner, officer: Chief Executive Officer 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak director 7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet director 390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden officer: Chief Financial Officer C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder director, officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn officer: Chief Financial Officer 61 DARREN DRIVE, BASKING RIDGE NJ 07920
Kimberly J Grant officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Shruti H Patel officer: Interim Corporate Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873